Search details
1.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37290468
2.
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
BMC Med
; 21(1): 94, 2023 03 16.
Article
in English
| MEDLINE | ID: mdl-36927541
3.
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
BMC Med
; 21(1): 464, 2023 11 27.
Article
in English
| MEDLINE | ID: mdl-38012705
4.
Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma.
BMC Cancer
; 23(1): 7, 2023 Jan 03.
Article
in English
| MEDLINE | ID: mdl-36597072
5.
Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
Eur Radiol
; 33(5): 3682-3692, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36735041
6.
Head and neck MRI-based T stage and [18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma.
Eur Radiol
; 33(11): 7952-7966, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37314471
7.
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
JAMA
; 330(20): 1961-1970, 2023 11 28.
Article
in English
| MEDLINE | ID: mdl-38015220
8.
Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
BMC Cancer
; 22(1): 880, 2022 Aug 11.
Article
in English
| MEDLINE | ID: mdl-35953777
9.
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
BMC Cancer
; 22(1): 1129, 2022 Nov 03.
Article
in English
| MEDLINE | ID: mdl-36329397
10.
First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study.
Cancer Control
; 29: 10732748221124868, 2022.
Article
in English
| MEDLINE | ID: mdl-36047451
11.
Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study.
Eur Radiol
; 32(11): 7722-7732, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35505116
12.
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(8): 2586-2598, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33420610
13.
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
BMC Cancer
; 21(1): 534, 2021 May 11.
Article
in English
| MEDLINE | ID: mdl-33975558
14.
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
BMC Cancer
; 21(1): 1320, 2021 Dec 09.
Article
in English
| MEDLINE | ID: mdl-34886807
15.
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Eur Radiol
; 31(7): 5222-5233, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33416977
16.
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
BMC Cancer
; 20(1): 89, 2020 Feb 03.
Article
in English
| MEDLINE | ID: mdl-32013967
17.
LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
PLoS Pathog
; 13(7): e1006503, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28732079
18.
Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
BMC Cancer
; 19(1): 908, 2019 Sep 11.
Article
in English
| MEDLINE | ID: mdl-31511059
19.
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
BMC Cancer
; 19(1): 92, 2019 Jan 21.
Article
in English
| MEDLINE | ID: mdl-30665378
20.
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.
J Natl Compr Canc Netw
; 17(6): 703-710, 2019 06 01.
Article
in English
| MEDLINE | ID: mdl-31200353